Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects

Abstract

IR, previously DM2 diagnosis, is a strong predictor of quantitative and qualitative features of lipoproteins directly associated with an increased atherogenic risk.